In this episode, 340B Report Publisher and CEO Ted Slafsky and Associate Editor and Senior Writers Shannon Young and Will Newton break down the latest in 340B news, including a major federal court ruling on drugmaker 340B rebate models, Health and Human Services (HHS) Secretary Robert F Kennedy Jr.’s first public comments on the 340B program and the Oklahoma governor’s decision to veto a widely supported contract pharmacy access bill.

Key Topics Covered:

Court Upholds HHS’ Right to Pre-Approve 340B Rebates

Will recaps the latest developments in a key 340B rebate lawsuit, including a recent opinion from the Washington D.C. U.S. District Court that rejected drugmakers’ claims that HHS acted unlawfully by requiring pre-approval of their 340B rebate proposals. He dives into the implications of the ruling, which doesn’t rule out the possibility of drugmaker rebates in the future, what it means for stakeholders and how key 340B players responded. 

RFK Jr. Offers 1st Public Comments on 340B, Trump Issues Drug Pricing EO 

Shannon breaks down Kennedy’s first public comments on the 340B program, which came during his recent testimony before House and Senate subcommittees. She and Ted discuss how the HHS secretary’s comments about the program largely reflect drug industry talking points, as well as the pushback the comments drew from 340B providers. Shannon also offers an update on budget reconciliation talks and discusses President Donald Trump’s new “most-favored nation” drug pricing executive order. She and Ted note the challenges the White House could face in advancing efforts to lower drug prices.

Oklahoma Governor Vetoes Contract Pharmacy Bill Following Dark-Money Campaign

Will provides an update on Oklahoma’s efforts to pass contract pharmacy access legislation after Gov. Kevin (R) vetoed a bill, which cleared the legislature with widespread support. Will discusses the role that misleading dark-money ads may have played in the governor’s decision, and how GOP lawmakers, who were the lead sponsors of the 340B legislation, are pushing to override that veto.

Subscribe & Stay Updated:

How to Follow Us and Learn More About This Episode’s Sponsor

Stay tuned for more episodes every other week! 🎧 Subscribe to Inside 340B Report on your favorite podcast platform or YouTube.

Each episode is brought to you by one of our great Ultra Diamond sponsors. RxParadigm sponsored this week’s episode. RxParadigm’s mission is to cultivate innovative approaches and technologies that promote transparency and authenticity, leading to enhanced outcomes, reduced overall healthcare costs, and effective 340B program administration.

Subscribe to 340B Report with a Special Discount

We’re offering a special discount for podcast listeners. 340B Report is the indispensable source for news and intelligence on the 340B program. First-time subscribers may subscribe now using coupon code PODCAST25. Not ready to subscribe? Sign up for a 15-day free trial.